Psychopharmacology Update!!!

Features Psychopharmacology Update!!!

Psychopharmacology Update features a licensed and Board Certified Psychiatric Pharmacist (BCPP) presenting an in-depth review over psychiatric medications that have recently been FDA approved.
This presentation incorporates an audio-synced slide deck with easy to use functionality to improve the learning experience.
This is a scholarly presentation that contains unbiased medication information (NO pharmaceutical sponsorship).
PRESENTATION OBJECTIVES:Schizophrenia - describe how antipsychotics work on the pathophysiology of schizophrenia to improve core symptoms - identify the basic dopamine pathways and their relationship with efficacy versus side effects - discuss a unique treatment option for antipsychotic-induced hyperprolactinemia - examine pharmacological characteristics of both 1st and 2nd generation antipsychotics - discuss differences between the newer antipsychotics - compare the mean increase in QTc prolongation for individual antipsychotics - review treatment goals, guidelines for selection, and monitoringDepression - discuss unique pharmacological characteristics of vilazodone (Viibryd™) and vortioxetine (Brintellix™) - review medication selection - examine potential receptor targets - describe the mechanism of antidepressant-induced sexual dysfunction
MEDICATIONS REVIEWED:Long-Acting Injectable Second Generation Antipsychotics - aripiprazole monohydrate (Abilify Maintena™) - olanzapine pamoate (Zyprexa® Relprevv™) - paliperidone palmitate (Invega® Sustenna®) - risperidone long-acting injectable (Risperdal® Consta®)
Second Generation Antipsychotic Oral Formulations - iloperidone (Fanapt®) - asenapine (Saphris®) - lurasidone (Latuda®)
First Generation Antipsychotic Inhalation Powder - loxapine inhalation powder (Adasuve®)
Antidepressants - vilazodone (Viibryd™) - vortioxetine (Brintellix™)
All aboard!
Come take a journey through the wonderful world of psychopharmacology!!!
Recommended by Appgovideo.com (http://www.appgovideo.com/)